Darren D. Brennan

Papers

Total Citations

238

H-Index

About

Darren D. Brennan is a leading figure in radiation oncology, with a focused research program on the treatment of pancreatic cancer. His work has been instrumental in advancing the use of stereotactic body radiotherapy (SBRT) for this challenging disease, particularly in combination with systemic therapies. Brennan’s most impactful contribution is his landmark 2010 study, “Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer,” which has garnered 232 citations. This work demonstrated the feasibility and potential of delivering high-dose, precisely targeted radiation alongside gemcitabine, offering a new paradigm for managing locally advanced, inoperable tumors. Earlier, his 2007 paper on fractionated radiosurgery for pancreas cancer laid crucial groundwork for these later, more refined protocols. Brennan’s research has helped shift the standard of care, providing patients with a non-invasive option that can improve local control and quality of life. His contributions are widely recognized within the radiation oncology community, and his work continues to inform clinical trials and treatment guidelines for one of the most lethal malignancies.